Synonyms: IDEC-2B8 | IDEC-Y2B8-yttrium ibritumomab tiuxetan | NSC-715848 | Zevalin®
ibritumomab tiuxetan is an approved drug (FDA (2002), EMA (2004))
Compound class:
Antibody
Comment: A monoclonal antibody used as a radioimmunotherapy treatment.
|
Bioactivity Comments |
The labelled antibody shows high affinity and selectivity for its target antigen [1]. We have been unable to find affinity data for the interaction between this antibody and CD20 in any open access article. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|